BioSIM 抗人 VSIG4/CRIg 抗体，生物类似药

BioSIM 抗人 VSIG4/CRIg 抗体，生物类似药，科研用途

产品概述

BioSIM 抗人 VSIG4/CRIg 抗体是一种高纯度的重组生物类似抗体，专门针对VSIG4/CRIg抗原设计。该抗体在无动物成分的设施中生产，采用先进的体外无蛋白细胞培养技术，并通过多步骤纯化工艺（包括Protein A或G色谱）确保高纯度和批次一致性。作为VTX-1218的生物类似药，该抗体专为科研用途设计，适用于多种免疫学检测和研究应用。

研究领域与应用

该抗体主要应用于晚期实体瘤研究领域，特别适用于以下应用类型：

• ELISA - 酶联免疫吸附测定
• FACS - 流式细胞术分析
• Functional assay - 功能性实验
• Research in vivo - 体内研究应用

生产特点

• 在无动物成分的设施中生产，降低动物源污染物风险
• 采用体外无蛋白细胞培养技术，确保产品无血清成分干扰
• 多步骤纯化工艺，包括Protein A或G色谱，确保高纯度
• 作为生物类似药，具有与原始药物相似的结构和功能特性

储存条件

为确保产品质量和稳定性，请遵循以下储存建议：

• 避免反复冻融，以保持抗体活性
• 短期储存（1-2周）：4°C
• 中期储存（最长12个月）：-20°C
• 长期储存：-80°C

免疫原性信息

BioSIM 抗人 VSIG4/CRIg 抗体的免疫原性详情请参考产品说明书。在使用前，请仔细阅读相关技术资料，以确保实验设计的合理性和安全性。

注意：以上信息可能随着产品优化升级等因素产生变动，具体信息请咨询亚科因公司。

BioSIM anti-Human VSIG4/CRIg Antibody, Biosimilar, for Research Use

Product Overview

BioSIM anti-Human VSIG4/CRIg Antibody is a high-purity recombinant biosimilar antibody specifically designed against VSIG4/CRIg antigen. The antibody is produced in animal component-free facilities using advanced serum-free in vitro cell culture technology, and undergoes multi-step purification processes (including Protein A or G chromatography) to ensure high purity and batch consistency. As a biosimilar of VTX-1218, this antibody is designed for research use and is suitable for various immunological assays and research applications.

Research Fields and Applications

This antibody is primarily used in the research field of advanced solid tumors, and is particularly suitable for the following application types:

• ELISA - Enzyme-Linked Immunosorbent Assay
• FACS - Flow Cytometry Analysis
• Functional assay - Functional experiments
• Research in vivo - In vivo research applications

Production Features

• Produced in animal component-free facilities to reduce the risk of animal-derived contaminants
• Utilizes serum-free in vitro cell culture technology to ensure no serum component interference
• Multi-step purification process including Protein A or G chromatography to ensure high purity
• As a biosimilar, it has similar structural and functional characteristics to the original drug

Storage Conditions

To ensure product quality and stability, please follow the storage recommendations below:

• Avoid repeated freeze-thaw cycles to maintain antibody activity
• Short-term storage (1-2 weeks): 4°C
• Medium-term storage (up to 12 months): -20°C
• Long-term storage: -80°C

Immunogenicity Information

For detailed immunogenicity information of BioSIM anti-Human VSIG4/CRIg Antibody, please refer to the product manual. Before use, carefully read the relevant technical documentation to ensure the rationality and safety of experimental design.

Note: The above information may change due to factors such as product optimization and upgrades. For specific information, please consult Yacoin Biotechnology.